Quantitative informant- and self-reports of subjective cognitive decline predict amyloid beta PET outcomes in cognitively unimpaired individuals independently of age and APOE ε4

dc.contributor.authorSánchez Benavides, Gonzalo
dc.contributor.authorSalvadó, Gemma
dc.contributor.authorArenaza Urquijo, Eider M.
dc.contributor.authorGrau Rivera, Oriol
dc.contributor.authorSuárez Calvet, Marc
dc.contributor.authorMilà Alomà, Marta
dc.contributor.authorGonzález de Echávarri, José M.
dc.contributor.authorMinguillón, Carolina
dc.contributor.authorCrous Bou, Marta
dc.contributor.authorNiñerola Baizán, Aida
dc.contributor.authorPerissinotti, Andrés
dc.contributor.authorGispert, Juan Domingo
dc.contributor.authorMolinuevo, José Luis
dc.contributor.authorALFA Study
dc.date.accessioned2022-05-04T14:35:49Z
dc.date.available2022-05-04T14:35:49Z
dc.date.issued2020-11-11
dc.date.updated2022-05-04T14:35:49Z
dc.description.abstractIntroduction: Amyloid beta (Aβ) pathology is an Alzheimer's disease early hallmark. Here we assess the value of longitudinal self- and informant reports of cognitive decline to predict Aβ positron emission tomography (PET) outcome in cognitively unimpaired middle-aged individuals. Methods: A total of 261 participants from the ALFA+ study underwent [18F]flutemetamol PET and Subjective Cognitive Decline Questionnaire (SCD-Q) concurrently, and 3 years before scan. We used logistic regressions to evaluate the ability of SCD-Q scores (self and informant) to predict Aβ PET visual read, and repeated analysis of variance to assess whether changes in SCD-Q scores relate to Aβ status. Results: Self-perception of decline in memory (odds ratio [OR] = 1.2), and informant perception of executive decline (OR = 1.6), increased the probability of a positive scan. Informant reports 3 years before scanning predicted Aβ PET outcome. Longitudinal increase of self-reported executive decline was predictive of Aβ in women (P = .003). Discussion: Subjective reports of cognitive decline are useful to predict Aβ and may improve recruitment strategies.
dc.format.extent10 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec723097
dc.identifier.issn2352-8729
dc.identifier.pmid33204815
dc.identifier.urihttps://hdl.handle.net/2445/185358
dc.language.isoeng
dc.publisherAlzheimer's Association
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1002/dad2.12127
dc.relation.ispartofAlzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring (DADM) , 2020, vol. 12, num. 1
dc.relation.projectIDinfo:eu-repo/grantAgreement/EC/H2020/752310/EU//BioALFA
dc.relation.urihttps://doi.org/10.1002/dad2.12127
dc.rightscc-by-nc (c) Sánchez Benavides, Gonzalo et al., 2020
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttps://creativecommons.org/licenses/by-nc/4.0/
dc.sourceArticles publicats en revistes (Biomedicina)
dc.subject.classificationMalaltia d'Alzheimer
dc.subject.classificationAmiloïdosi
dc.subject.classificationTrastorns de la cognició
dc.subject.classificationSímptomes
dc.subject.classificationDiagnòstic
dc.subject.otherAlzheimer's disease
dc.subject.otherAmyloidosis
dc.subject.otherCognition disorders
dc.subject.otherSymptoms
dc.subject.otherDiagnosis
dc.titleQuantitative informant- and self-reports of subjective cognitive decline predict amyloid beta PET outcomes in cognitively unimpaired individuals independently of age and APOE ε4
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
723097.pdf
Mida:
375.88 KB
Format:
Adobe Portable Document Format